Skip to main content

Table 3 Induction treatment response (n = 107)

From: Clinical outcomes and prognostic factors to predict treatment response in high risk neuroblastoma patients receiving topotecan and cyclophosphamide containing induction regimen: a prospective multicenter study

Treatment response

N (%)

Complete response (CR)

2 (1.9)

Very good partial response (VGPR)

40 (37.4)

Partial response (PR)

46 (43)

Mixed response (MR)

19 (17.8)

No response (NR)

–

Progressive disease (PD)

–

  1. Notes: Data are presented as number (%) for categorical variables